Esophageal Cancer Clinical Trial

Phase II Study of Pre-Operative Chemotherapy in Patients With Resectable Local-Regional Carcinoma of Esophagus

Summary

This study is designed pre-operative for patients with resectable, local-regional carcinoma of the esophagus.

View Full Description

Full Description

This study is designed for patients with resectable, local-regional carcinoma of the esophagus. In a pre-operative setting, chemotherapy with Taxol, Cisplatin, and 5-Fluorouracil will be administered followed by G-CSF.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Measurable disease with resectable local-regional carcinoma of the esophagus. 18 years of age or older.

Exclusion Criteria:

Pregnant or lactating. Non-resectable local-regional carcinoma of the esophagus.

Study is for people with:

Esophageal Cancer

Phase:

Phase 2

Estimated Enrollment:

20

Study ID:

NCT00208936

Recruitment Status:

Terminated

Sponsor:

Emory University

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Emory University Winship Cancer Institute
Atlanta Georgia, 30322, United States

How clear is this clinincal trial information?

Study is for people with:

Esophageal Cancer

Phase:

Phase 2

Estimated Enrollment:

20

Study ID:

NCT00208936

Recruitment Status:

Terminated

Sponsor:


Emory University

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider